# OnCo record zydus (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/zydus/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "zydus" ;
  schema:name "Zydus Lifesciences"@en ;
  schema:description "Zydus Lifesciences, a large Ahmedabad drug maker founded in 1952, sells oncology generics and biosimilars in India and won US approval in October 2024 for generic enzalutamide, a hormone-blocking pill for prostate cancer. Its US generics pipeline is the route by which Indian manufacturing pressure reaches cancer drug prices."@en ;
  schema:url <https://onco.cc/companies/zydus/>, <https://www.zyduslife.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.zyduslife.com> ;
  schema:addressCountry "IN" ;
  onco:sections <https://onco.cc/fronts/hormonal/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:drugs <https://onco.cc/drugs/enzalutamide/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/> .